This vaccine is an antiidiotypic vaccine targeting N-glicolil GM3, a tumor specific antigen.

A vaccine targeting the E. coli infection that causes most urinary tract infections would not have saved Bridi, but it could keep millions of people from becoming infected each year and save the health care system billions of dollars a year, Griebling says.

A second vaccine targeting HPV16 and 18 has had similar efficacy.

June 17, 2011 - Health officials in Australia are reporting what may prove to be the first evidence that the vaccine targeting the human papillomavirus (HPV) could prevent cervical cancer in a large population.

Small portions of L2 are well-conserved between different papillomavirus types, and experimental vaccines targeting these conserved domains may offer protection against a broad range of HPV types.

Several potential vaccines targeting the pre-erythrocytic stage of the parasite's life cycle are being developed, with RTS,S as the leading candidate; it is expected to be licensed in 2015.

A second vaccine targeting HPV 16 and 18 has had similar efficacy (Cervarix, Glaxo Smith Kline, Research Triangle Park, North Carolina) (907) and is expected to receive FDA approval in 2009.

Several potential vaccines targeting the pre-erythrocytic stage are being developed, with RTS,S showing the most promising results so far.

Research is underway on this, yet production of an actual vaccine targeting these protein kinases may still take a long time.

A vaccine targeting several antigens may require delivery to different areas and by different means in order to elicit an effective response.